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Intracranial hemorrhage is a rare and fatal presentation of leptospirosis. In this paper we present the case of a 51-year-old male
farmer who lives in northern Iran. He came to our hospital with a severe headache. A paraclinical evaluation showed clear signs of
thrombocytopenia, and a brain MRI revealed left temporoparietal hemorrhage. Our preliminary diagnosis was Leptospirosis, and
after 26 days of hospital care the patient was discharged in good condition. This paper will educationally help physicians in better




globally, but the real incidence is higher [1]b e c a u s eo f
clinical and laboratory limitation diagnosing the disease.
The disease presents with variable combinations of clinical
syndromes, which cause diagnostic confusion with many
infectious and noninfectious diseases. Diagnostic problems
have been presented in neuroleptospirosis. When a patient
is infected with leptospirosis, the central nervous system is
aﬀected by aseptic meningitis or encephalitis (more rarely),
and the peripheral nervous system suﬀers from neuritis,
polyneuritis, and polyradiculoneuritis [2–4]. Other clinical-
forms of neuroleptospirosis are intracranial hemorrhages,
cerebellitis, and myelitis [1, 5]. In most cases, hemorrhage
due to leptospirosis occurs in the pulmonary and gastroin-
testinal systems but not in the central nervous system [6]. In
this paper we present a rare case of leptospirosis (Weil’s dis-
ease) in a patient who came to our center (Razi Hospital in
Ghaemsharcity,Mazandaranprovince,Iran).Inthepatient’s
laboratory data we observed renal function impairment,
increased liver enzymes, and a decreased platelet count
(5,000).
2. Case Presentation
The patient is a 51-year-old man who arrived at our
facility complaining of fever, chills, myalgia, and generalized
weakness that had begun 5 days before coming to the
hospital. His fever was continuous, and he reported that
his eyes have been yellow for the previous 3 days; he also
complained of a headache in the frontal area. He is a ﬁshery
oﬃcer and works in the rice paddies as well. He reported
severe vomiting 4 to 5 times per day and a decreased appetite
and a change in urine color during the previous few days.
The patient had no signiﬁcant familial history of any
disease. Except for one capsule of Omeprazole (20mg) each
day for heartburn; he reported no other current medications
and no history of drug abuse history. The patient’s physical
examination showed the following vital signs: blood pressure
120/80mmHG, pulse of 80, respiratory rate of 18, and
temperature of 38◦C.
His conjunctiva was congested. No neck stiﬀness was
detected. On both arms multiple petechia and, purpura were
observed,buttherewasnosignofecchymosis.Theheartbeat
was normal. No organomegaly was detected in an abdominal
examination. The lower limbs had normal appearance and
function.2 Case Reports in Medicine
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Figure 1: The patient’s CT scan.
Table 1: Laboratory data.
Test Patient’s data Normal value SI units
WBC 14100/mcL 3800–9800/mcL 3.8–9.8 × 109/L
RBC 3530000/mcL 4.3–5.9 ×
106/mcL 4.3–5.9 × 1012/L
PLT 5000/mcL 150–450 ×
103/mcL 150–450 × 109/L
HgB 10.6gr/dL 13.8–17.5g/dL 138–175g/L
Creatinine 2.8g/day 0.8–1.8g/day 7.1–15.9mmol/day
FBS 117mg/dL 65–115 mg/dL 3.6–6.3mmol/L
CK 2990ng/mL 174–320ng/mL 0.5–3.67mckat/L
Amylase 350IU/L 35–118IU/L 0.58–1.97mckat/L
LDH 900IU/L 100–250 IU/L 1.67–4.17mckat/L
INR 1.0 0.9–1.2 0.9–1.2
AST 395IU/L 11–47IU/L 0.18–0.78mckat/L
ALT 250IU/L 7–53IU/L 0.12–0.88mckat/L
ALP 160IU/L 20–130IU/L 20–130IU/L
PT 12.5s 10–14s 10–14s
PTT 42s 32–45s 32–45s
ESR 98mm/hr ≤30mm/hr ≤30mm/hr






bilirubin 49mg/dL 0.1–1mg/dL 2–18mcmol/L
Direct
bilirubin 45.3mg/dL 0.1–1mg/dL 2–18mcmol/L
The laboratory data are shown in Table 1.
After a brain CT scan the radiologist reported “multiple
hemorrhagic lesions in the temporal and parietal lobes, es-
pecially in the left side” (see Figure 1).
Thepatient ’ sc hestX-ra ywasnormal,andhet est ednega-
tive for HBs Ag and HBs AB.
His diagnosis was reviewed, and in view of the deranged
hepatorenal functions and seasonal prevalence (recent ﬂoods
in the area where the patient resided), leptospirosis was
clinically suspected, which was further conﬁrmed by the
positive serum IgM-ELISA (IgG value of 100 and an IgM
valueof20).Epidemicsofleptospirosisinourregionandun-
availability of Microscopic agglutination test (MAT) made us
to consider IgM-ELISA for conﬁrmation of leptospirosis.
In an abdominal sonography, 70cc of ﬂuid were found in
Morison’spouch,andtheliverexhibitedhepatitis-likechang-
es. An MRI showed intracranial hemorrhage, especially in
the left lobe.
With intracranial hemorrhage care and Ceftriaxone
(1mg/day) and Dexamethasone (8mg two times daily) for 1
week and 15 unit platelets, his condition improved. After 26
daysofhospitalcarewithanormalplateletcountandnormal
renal function the patient was discharged from hospital.
3. Discussion
A study of 59 patients admitted to the Philippine General
Hospital in July to November 1995 and June to October1996
showed that a prevalence rate of 61% for thrombocytopenia
and its presence seem to indicate a more severe form
of the disease. Most cases of thrombocytopenia are of
moderate severity, and Casiple’s ﬁndings revealed increased
bleeding complications in the thrombocytopenic group.
Mortality was also higher in the thrombocytopenic group.
The majority of mortalities in this sample were associated
with hemorrhagic causes, the most common of which was
pulmonary hemorrhage (42%) [7].
Hospitalized patients often present with thrombocytope-
nia, hemorrhagic symptoms, jaundice, and renal failure. Pa-
tients in this situation usually die from septic shock compli-
catedbymultiorganfailureorableedingdiathesis[8].Patho-
logical ﬁndings have revealed widespread hemorrhaging at
mucosal surfaces, muscles, peritoneum, and various organs
such as the heart, lungs, and kidneys in thrombocytopenic
patients [9, 10]. In general, thrombocytopenia is frequently
observed and associated with poor outcomes [11, 12].Case Reports in Medicine 3
A small proportion of patients develop severe icteric
illness with renal failure. Jaundice occurs between the fourth
and the sixth day but may occur as early as the second day or
as late as the second to third week. The liver is often enlarg-
ed and tender. Jaundice is due to hepatocellular necro-
sis, intrahepatic cholestasis, and increased bilirubin load
from absorption of tissue hemorrhage. Marked elevations
of bilirubin with mildly elevated transaminases are some
characteristic features of leptospirosis [13]. Neurological
involvement in leptospirosis can present as meningitis,
aseptic encephalitis, inﬂammatory myelopathy, Guillain-
Barre syndrome, and stroke. Intracranial hemorrhage due to
severethrombocytopeniaisararecomplicationofWeil’ssyn-
drome [14–16].
In leptospirosis, as in other infectious diseases, the bleed-
ing tendency is the result of imbalance in the haemostatic
equilibrium, although it is unclear how this imbalance is
triggered and what inﬂammatory and coagulation proteins
are involved [17].
Panaphut and colleagues reported that “Ceftriaxone and
sodium penicillin G were equally eﬀective for the treatment
of severe leptospirosis. Once-daily administration and the
extended spectrum of Ceftriaxone against bacteria provide
additional beneﬁts over intravenous penicillin.” We also use
Ceftriaxone for treatment of severe case, and so far we hade
satisfaction from results [18].
Leptospirosis is one of the world’s most prevalent zoon-
oses,withaclinicalpicturevaryingfromamildtopotentially
life-threatening disease in which haemostatic derangements
play a central role. Despite these facts, leptospirosis is a
neglected disease, which explains why many crucial aspects
concerning its pathogenesis remain unanswered. Besides
proper diagnosis and antibiotic therapy, which is the corner-
stone of treatment, we urgently need to improve supportive
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